BCAT1 and chronic myelogenous leukemia, BCR-ABL1 positive: BCAT1 is also aberrantly activated in CML, and blocking BCAT1 gene expression or enzymatic activity induces cellular differentiation and impairs the propagation of blast crisis CML (79).